Add Yahoo as a preferred source to see more of our stories on Google. A sign stands outside Chinese drugmaker Innovent Biologics' office in Shanghai, China July 11, 2025. REUTERS/Andrew Silver ...

GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications primarily used in the management of type 2 ...

China now accounts for the largest population affected by type 2 diabetes worldwide, with prevalence rising steeply over the past four decades. Rapid urbanisation, changes in dietary patterns towards ...

Two or more weekly hours of resistance training reduces type 2 diabetes risk; however, concurrent aerobic and strength training achieves the lowest risk, underscoring the efficacy of combined exercise ...

SHANGHAI (Reuters) -China's Innovent Biologics said on Monday its GLP-1 injection led to more weight loss and better control of blood sugar in patients with diabetes than injectable semaglutide, the ...